Sanofi shares fell after the company said Belen Garijo, the chief executive of Germany’s Merck KGaA, would succeed Paul ...

The sudden departure stands in contrast to other EU pharma leaders who have been given much longer transitions in recent ...

Sanofi is replacing Paul Hudson as CEO, amid questions about which medicines will drive the company's growth in the future.

Sanofi said Belen Garijo, the chief executive of Merck KGaA, would succeed Paul Hudson as CEO after the board of directors decided not to renew Hudson's mandate.

Sanofi abruptly replaced Chief Executive Officer Paul Hudson after a massive research spending boost failed to deliver rapid ...

Sanofi sold its controlling stake in the drugmaker’s consumer-health unit last year, meaning it’s now entirely reliant on innovative prescription medicines.

Sanofi’s Board of Directors announced Belén Garijo as the company’s next CEO following the move to not renew the tenure of ...

PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern medicine. The event is scheduled for 20-21 April in Amsterdam. Trust and ...

BridgeBio is hoping infigratinib will get another shot at approval after the medicine hit the key goals of a phase 3 study in ...

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...

Vetnique Labs ("Vetnique"), a leading vet-recommended pet health and wellness company, today announced that consumer industry leader Noel Geoffroy has been named Global CEO, responsible for leading ...